What is the survival rate for triple-positive breast cancer? The relative 5-year survival rate for stage 3 breast cancer is 86 percent, according to the American Cancer Society . This means that out of 100 people with stage 3 breast cancer, 86 will survive for 5 years.
Is triple-positive breast cancer worse? Triple-Positive vs.
At first glance, it would seem triple-positive breast cancer would offer the best prognosis, followed by tumors that are ER-positive or HER2-positive, with triple-negative tumors having the worst outcomes. However, that doesn’t appear to be the case.
Is triple-positive breast cancer treatable? See Triple-negative Breast Cancer to learn more. Triple-positive breast tumors are HER2-positive, ER-positive, and PR-positive. These cancers are treated with hormone drugs as well as drugs that target HER2.
What does it mean to have triple-positive breast cancer? “Triple-positive” refers to breast tumors that are ER-, PR- and HER2-positive. It means the cancer cells grow in response to estrogen (ER), progesterone (PR) and a growth-promoting protein that’s on the outside of all breast cells known as HER2.